Bath & Body Works (BBWI) Expected to Announce Earnings on Wednesday

Bath & Body Works (NYSE:BBWI) will likely be releasing its Q2 2027 results before the market opens on Wednesday, August 26th. Analysts expect the company to post earnings of $0.2434 per share and revenue of $1.4973 billion for the quarter. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Investors are encouraged to explore the company’s upcoming Q2 2027 earning report for the latest details on the call scheduled for Wednesday, August 26, 2026 at 8:30 AM ET.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was down 3.2% on a year-over-year basis. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bath & Body Works Trading Up 0.1%

Shares of NYSE:BBWI opened at $19.47 on Monday. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $32.32. The company’s 50 day moving average is $20.47 and its two-hundred day moving average is $20.08. The company has a market cap of $3.92 billion, a PE ratio of 5.47, a P/E/G ratio of 1.92 and a beta of 1.38.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s dividend payout ratio is 22.47%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. JPMorgan Chase & Co. raised their price target on Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research note on Tuesday, August 18th. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 price objective on shares of Bath & Body Works in a report on Monday, July 6th. UBS Group reissued a “neutral” rating on shares of Bath & Body Works in a research report on Wednesday. Jefferies Financial Group boosted their target price on Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Finally, Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a report on Tuesday, August 18th. Four analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $22.57.

Hedge Funds Weigh In On Bath & Body Works

Several large investors have recently bought and sold shares of BBWI. Invesco Ltd. increased its position in shares of Bath & Body Works by 43.6% during the fourth quarter. Invesco Ltd. now owns 652,991 shares of the company’s stock worth $13,112,000 after purchasing an additional 198,324 shares in the last quarter. Corient Private Wealth LLC lifted its holdings in shares of Bath & Body Works by 475.8% in the 4th quarter. Corient Private Wealth LLC now owns 97,202 shares of the company’s stock valued at $1,952,000 after purchasing an additional 80,322 shares during the last quarter. Alberta Investment Management Corp acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at about $1,135,000. Mercer Global Advisors Inc. ADV boosted its position in shares of Bath & Body Works by 39.3% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 161,935 shares of the company’s stock valued at $3,252,000 after purchasing an additional 45,713 shares during the period. Finally, XTX Topco Ltd grew its stake in Bath & Body Works by 65.2% during the 4th quarter. XTX Topco Ltd now owns 80,548 shares of the company’s stock worth $1,617,000 after buying an additional 31,781 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.